Fresenius Medical Care AG – Consensus Says Potential 23.5% Increase


Fresenius Medical Care AG found using ticker (FMS) now have 5 analysts covering the stock. Analyst consensus indicates a rating of “Hold”. The target price is between 45.76 and 32.24 with an average TP of 37.88. Given that the previous close for shares was at 30.67, this indicates that there is a potential upside of 23.5%. The 50 day moving average is 33.27 while the 200 day moving average is 37.57. The company has a market capitalization of $ 17,961 million. You can visit the company’s website by visiting:

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, follow-up assistance and organization of delivery of supplies to the patient’s home; and contract dialysis services with hospitals in the United States for inpatients with end-stage renal disease (ESRD) and for patients with acute kidney disease. The company also develops, manufactures and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cycles, peritoneal dialysis solutions, hemodialysis concentrates, granules and solutions, blood lines, renal pharmaceuticals and water treatment systems; and products other than dialysis, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires and licenses renal pharmaceuticals; provides medications and kidney supplies to patients at home or at dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, outpatient vascular care surgery center, and physician nephrology and cardiology services. The company sells its products directly to dialysis clinics, hospitals and specialty treatment clinics, as well as through local sales forces, independent distributors, resellers and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

You can now share this on Stocktwits, just click on the logo below and add the ticker in the text to be seen.

Source link


Comments are closed.